# FDA Inspection 1109483 - Shiratori Pharmaceutical Co. Ltd. - October 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/shiratori-pharmaceutical-co-ltd/6e636b2f-69f2-4e32-bc78-3f79a418cdc3
Source feed: FDA_Inspections

> FDA Inspection 1109483 for Shiratori Pharmaceutical Co. Ltd. on October 18, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1109483
- Company Name: Shiratori Pharmaceutical Co. Ltd.
- Inspection Date: 2019-10-18
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 994527 - 2016-11-04](https://www.keypedia.com/records/fda_inspections/shiratori-pharmaceutical-co-ltd/9c1fa683-2835-4a2e-b993-95865b286eec)
- [FDA Inspection 855403 - 2013-11-06](https://www.keypedia.com/records/fda_inspections/shiratori-pharmaceutical-co-ltd/658e61e0-acc5-454f-bbd4-f36fc209b9f2)

Company: https://www.keypedia.com/companies/shiratori-pharmaceutical-co-ltd/01241000-a572-47a5-a78f-1cd20f5971bc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
